Mismatch Repair Deficient (dMMR)
5 clinical trials · Condition
◉ Watch Mismatch Repair Deficient (dMMR)
| Record | Firm | Date |
|---|---|---|
| Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer (NCT05371197) | Third Affiliated Hospital, Sun Yat-Sen University | 2022-05-05 |
| Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer (NCT03926338) | Sun Yat-sen University | 2019-05-10 |
Track Mismatch Repair Deficient (dMMR) automatically
Every clearance here is in the API, with alerts when new ones post.